| Trial ID: | L4771 |
| Source ID: | NCT00832390
|
| Associated Drug: |
Sitagliptin Phosphate
|
| Title: |
Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00832390/results
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: sitagliptin phosphate
|
| Outcome Measures: |
Primary: Change From Baseline in A1C at Week 24, Week 24 A1C minus baseline (Week 0) A1C. The unit for A1C is "percent". Thus, this measure represents a difference of percent values., Baseline and 24 Weeks |
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
29
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-02-14
|
| Completion Date: |
2008-07-11
|
| Results First Posted: |
2009-07-31
|
| Last Update Posted: |
2017-05-30
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00832390
|
